Advertisement
Advertisement
Asmalin

Asmalin Warnings

salbutamol

Manufacturer:

UNILAB, Inc

Distributor:

UNILAB, Inc
Full Prescribing Info
Warnings
Syrup: Seek medical advice if either the usual relief is diminished or the usual duration of action is reduced. Do not increase the dose or frequency of administration.
Pulmoneb: If a previously effective dose fails to provide the usual relief or the usual duration of action is reduced, consult a physician for medical advice as this is a sign of worsening of asthma that would require reassessment of therapy.
Excessive use of sympathomimetic oral inhalations has been associated with fatalities in asthmatic patients. The exact cause of death is unknown but cardiac arrest following severe, acute asthmatic crisis and hypoxia is suspected.
Paradoxical bronchospasm, a potentially life-threatening event, may occur with the first use of a new ampoule. If it occurs, discontinue Salbutamol immediately and institute alternative therapy.
Immediate hypersensitivity reactions including urticaria, angioedema, rash, bronchospasm, anaphylaxis, and oropharyngeal edema may occur rarely after administration of the product.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement